Showing results (2621-2630 of 2,814) with videos related to

Sort By:
Pageof 282
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 3, 2024
Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient RecordsVirginia H Sun, Julius C Heemelaar, Ibrahim Hadzic, et al.
Nature Communications|June 19, 2026
Mechanistic and antigenic boundaries of Henipavirus and Parahenipavirus glycoproteinsAaron J May, Muralikrishna Lella, Jared Lindenberger, et al.
Earth and Space Science (Hoboken, N.J.)|November 4, 2017
The Mars Science Laboratory (MSL) Mast cameras and Descent imager: Investigation and instrument descriptionsMichal C Malin, Michael A Ravine, Michael A Caplinger, et al.
Journal for Immunotherapy of Cancer|September 21, 2021
Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancerLeyre Zubiri, Gabriel E Molina, Meghan J Mooradian, et al.
Lancet (London, England)|January 21, 2024
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b studyJeffrey S Weber, Matteo S Carlino, Adnan Khattak, et al.
Nature Medicine|June 2, 2023
Pembrolizumab in brain metastases of diverse histologies: phase 2 trial resultsPriscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, et al.
Neuro-Oncology Pediatrics|March 30, 2026
Alternative splicing in pediatric central nervous system tumors highlights oncofetal candidate CLK1 exon 4Ammar S Naqvi, Patricia J Sullivan, Ryan J Corbett, et al.
Journal for Immunotherapy of Cancer|November 28, 2025
International real-world study of combination immunotherapy sequences in metastatic melanomaMora Guardamagna, Sarah E Lochrin, James William Smithy, et al.
Nature Communications|October 13, 2021
Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosisPriscilla K Brastianos, Matthew R Strickland, Eudocia Quant Lee, et al.
Nature Medicine|June 3, 2020
Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosisPriscilla K Brastianos, Eudocia Quant Lee, Justine V Cohen, et al.
Pageof 282